Paper Details

  1. Home
  2. Paper Details

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Author: AmanMichael G, ArnoldL Eugene, BrownNicole V, Buchan-PageKristin A, Corbett-DickPatricia, HandenBenjamin L, HellingsJessica, HollwayJill A, HurtElizabeth A, HymanSusan L, LecavalierLuc, LevatoLynne, McAuliffe-BellinSarah, MruzekDaniel W, PanXueliang, RiceRobert R, RyanMelissa M, SilvermanLaura B, SmithTristram, TumuluruRameshwari V

Clinical Trial, Phase IVPost-marketing surveillance. Monitors long-term safety/efficacy after approval.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates the individual and combined effectiveness of atomoxetine (ATX) and parent training (PT) for treating attention-deficit/hyperactivity disorder (ADHD) symptoms and noncompliance in children with autism spectrum disorder (ASD). ADHD is common in children with ASD, and this study aims to improve treatment strategies.
Paper Details　
Original Abstract of the Article :
Impairments associated with attention-deficit/hyperactivity disorder (ADHD) and noncompliance are prevalent in children with autism spectrum disorder (ASD). However, ADHD response to stimulants is well below rates in typically developing children, with frequent side effects. Group studies of treatme...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/26506581

データ提供：米国国立医学図書館（NLM）

ADHD and Autism: A Challenging Desert of Behavior

Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are two challenging conditions that can affect behavior, like navigating a desert with shifting sands. This study explores the effectiveness of atomoxetine (ATX) and parent training (PT) in treating ADHD symptoms and noncompliance in children with ASD. The authors found that both ATX and PT were effective individually, with a combination approach showing the most promising results. It's like finding a sturdy camel and a reliable guide to help navigate the challenging terrain of these behaviors.

Atomoxetine and Parent Training: A Combined Approach for Managing ADHD and Autism

This study suggests that a combination of atomoxetine (ATX) and parent training (PT) may be an effective strategy for managing ADHD symptoms and noncompliance in children with ASD. It's like finding a team that can work together to overcome the obstacles of this challenging desert.

Navigating the Desert of Behavioral Challenges

This research highlights the importance of individualized treatment approaches for children with ASD and ADHD. A combination of medication and behavioral therapy may be the key to navigating the desert of behavioral challenges and achieving positive outcomes. It's like finding the right tools and skills to not only traverse the desert but to also create a more stable and sustainable environment for those who live there.

Dr. Camel's Conclusion

This study provides important insights into the potential for treating ADHD and noncompliance in children with ASD. It's like finding a new path through the desert of behavioral challenges, offering hope for improved outcomes and a better quality of life for these children and their families.

Date :
  1. Date Completed 2016-11-01
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

26506581

DOI: Digital Object Identifier

NIHMS727297

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.